Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.

MLA

Wen, Zhi-Peng, et al. “Knockdown ATG4C Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Suppressing Autophagic Flux.” Journal of Experimental & Clinical Cancer Research : CR, vol. 38, no. 1, July 2019, p. 298. EBSCOhost, https://doi.org/10.1186/s13046-019-1287-8.

APA

Wen, Z.-P., Zeng, W.-J., Chen, Y.-H., Li, H., Wang, J.-Y., Cheng, Q., Yu, J., Zhou, H.-H., Liu, Z.-Z., Xiao, J., & Chen, X.-P. (2019). Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux. Journal of Experimental & Clinical Cancer Research : CR, 38(1), 298. https://doi.org/10.1186/s13046-019-1287-8

Chicago

Wen, Zhi-Peng, Wen-Jing Zeng, Yan-Hong Chen, He Li, Jie-Ya Wang, Quan Cheng, Jing Yu, et al. 2019. “Knockdown ATG4C Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Suppressing Autophagic Flux.” Journal of Experimental & Clinical Cancer Research : CR 38 (1): 298. doi:10.1186/s13046-019-1287-8.